Skip Navigation

Open Letter to Fiscal Conservatives on House Commerce Committee Concerning HF4 (Minnesota)

March 18, 2019

Letter to Minnesota lawmakers on House File No. 4, a bill that addresses generic drug pricing.

stethoscope and insurance docs
The National Taxpayers Union objects to measures to control prescription drug prices at the state level.  It argues that a process to review price setting could lead to cost hikes farther down the supply chain by limiting the availability of drugs and leading to more expensive treatments, like hospitalization.
Author
Pete Sepp is executive vice president of the National Taxpayers Union.
pressguy@ntu.org